Neuropediatrics 2014; 45(02): 117-119
DOI: 10.1055/s-0033-1349225
Short Communication
Georg Thieme Verlag KG Stuttgart · New York

Glucose Transporter Type 1 Deficiency Syndrome Effectively Treated with Modified Atkins Diet

Authors

  • Edda Haberlandt

    1   Department of Pediatrics I, Innsbruck Medical University, Innsbruck, Austria
  • Daniela Karall

    1   Department of Pediatrics I, Innsbruck Medical University, Innsbruck, Austria
  • Veronika Jud

    1   Department of Pediatrics I, Innsbruck Medical University, Innsbruck, Austria
  • Sara Sigl Baumgartner

    1   Department of Pediatrics I, Innsbruck Medical University, Innsbruck, Austria
  • Sibylle Zotter

    1   Department of Pediatrics I, Innsbruck Medical University, Innsbruck, Austria
  • Kevin Rostasy

    1   Department of Pediatrics I, Innsbruck Medical University, Innsbruck, Austria
  • Matthias Baumann

    1   Department of Pediatrics I, Innsbruck Medical University, Innsbruck, Austria
  • Sabine Scholl-Buergi

    1   Department of Pediatrics I, Innsbruck Medical University, Innsbruck, Austria
Further Information

Publication History

15 June 2012

06 May 2013

Publication Date:
25 July 2013 (online)

Preview

Abstract

This is a report on the successful treatment of a 6-year-old girl with genetically proven glucose transporter type 1 deficiency syndrome (GLUT1-DS) with modified Atkins diet (MAD). GLUT1-DS is an inborn disorder of glucose transport across the blood–brain barrier, which leads to energy deficiency of the brain with a broad spectrum of neurological symptoms including therapy-resistant epilepsy. Usually classical ketogenic diet (KD) is the standard treatment for patients with GLUT1-DS. Treatment with MAD, a variant of KD, for an observation period of 17 months resulted in improvement of seizures, alertness, cognitive abilities, and electroencephalography in this patient.